CVS Group plc Confirmation of dividend dates (1347Q)

TIDMCVSG

RNS Number : 1347Q

CVS Group plc

13 October 2023

CVS Group plc

("CVS" or the "Company")

Confirmation of dividend dates

CVS, one of the UK's leading providers of integrated veterinary services, confirms that the Board is recommending a continuation of our progressive dividend policy, with the payment of a final dividend of 7.5p per Ordinary share, as disclosed in our 2023 annual report.

The ex-dividend date is 2 November 2023, with a dividend record date of 3 November 2023. The dividend payment date is 8 December 2023.

Contacts:

CVS Group plc

via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

About CVS Group plc ( www.cvsukltd.co.uk )

CVS Group is an AIM-listed provider of veterinary services in the UK, Australia, the Netherlands and the Republic of Ireland. CVS is focused on providing high quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group has c.500 veterinary practices across its four markets, including nine specialist referral hospitals and 39 dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices), Buying Groups and the Group's online retail business ("Animed Direct").

The Group employs c.8,800 personnel, including c.2,300 veterinary surgeons and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DIVFLFLRIRLVLIV

(END) Dow Jones Newswires

October 13, 2023 12:21 ET (16:21 GMT)

CVS (AQSE:CVSG.GB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024